Evaxion AS (EVAX)

4.55 -0.24 (-5.01%) USD  |  NASDAQ  |  Jan 16, 16:00
4.60 +0.05 (+1.10%) After-Hours: 20:00
More

Evaxion Current Deferred Revenue (Per Share)

Current Deferred Revenue (Per Share) Chart

View Current Deferred Revenue (Per Share) for EVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Deferred Revenue (Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Deferred Revenue (Per Share) Range, Past 5 Years

View Current Deferred Revenue (Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Deferred Revenue (Per Share) Benchmarks

View Current Deferred Revenue (Per Share) Benchmarks
Start Trial
Novo Nordisk A/S --
Ascendis Pharma A/S --
DBV Technologies SA --
Cellectis SA Upgrade
Akari Therapeutics Plc --